Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1293455.RA9Ngz5dOQAOtYGFJwOMZ3n6mUlw9rifNbXQj70oGvmFQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1293455.RA9Ngz5dOQAOtYGFJwOMZ3n6mUlw9rifNbXQj70oGvmFQ130_assertion type Assertion NP1293455.RA9Ngz5dOQAOtYGFJwOMZ3n6mUlw9rifNbXQj70oGvmFQ130_head.
- NP1293455.RA9Ngz5dOQAOtYGFJwOMZ3n6mUlw9rifNbXQj70oGvmFQ130_assertion description "[The introduction of kinase inhibitors in cancer medicine has transformed chronic myeloid leukemia from a fatal disease into a leukemia subtype with a favorable prognosis by interfering with the constitutively active kinase BCR-ABL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1293455.RA9Ngz5dOQAOtYGFJwOMZ3n6mUlw9rifNbXQj70oGvmFQ130_provenance.
- NP1293455.RA9Ngz5dOQAOtYGFJwOMZ3n6mUlw9rifNbXQj70oGvmFQ130_assertion evidence source_evidence_literature NP1293455.RA9Ngz5dOQAOtYGFJwOMZ3n6mUlw9rifNbXQj70oGvmFQ130_provenance.
- NP1293455.RA9Ngz5dOQAOtYGFJwOMZ3n6mUlw9rifNbXQj70oGvmFQ130_assertion SIO_000772 26321002 NP1293455.RA9Ngz5dOQAOtYGFJwOMZ3n6mUlw9rifNbXQj70oGvmFQ130_provenance.
- NP1293455.RA9Ngz5dOQAOtYGFJwOMZ3n6mUlw9rifNbXQj70oGvmFQ130_assertion wasDerivedFrom befree-2016 NP1293455.RA9Ngz5dOQAOtYGFJwOMZ3n6mUlw9rifNbXQj70oGvmFQ130_provenance.
- NP1293455.RA9Ngz5dOQAOtYGFJwOMZ3n6mUlw9rifNbXQj70oGvmFQ130_assertion wasGeneratedBy ECO_0000203 NP1293455.RA9Ngz5dOQAOtYGFJwOMZ3n6mUlw9rifNbXQj70oGvmFQ130_provenance.